My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

234.00 +1.64 (+0.71%)

Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

89 90 Next >

Hedge Fund Favorites: 7 Stocks to Buy When You’re Feeling Jittery ↗

June 06, 2024

With the hedge funds targeting certain ideas with their vast resources, retail investors can ride coattails with these stocks to buy.

Via InvestorPlace

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential ↗

June 05, 2024

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.

Via InvestorPlace

2 High-Yield Dividend Stocks to Buy Right Now ↗

June 05, 2024

These two high-yield dividend stocks are top buys right now.

Via The Motley Fool

Analyst Scoreboard: 6 Ratings For AbbVie ↗

June 05, 2024

Via Benzinga

The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme ↗

June 05, 2024

Top dividend stocks across various sectors continue to reward investors, even as they face sales shortfalls and leadership changes.

Via InvestorPlace

Top Stocks to Buy in June ↗

June 04, 2024

Here are a few high-quality stocks trading at intriguing valuations.

Via The Motley Fool

AbbVie's Options Frenzy: What You Need to Know ↗

June 03, 2024

Via Benzinga

Evolus: Chiseling Away At The Aesthetic Market ↗

May 25, 2024

Via Talk Markets

This Is What Whales Are Betting On AbbVie ↗

May 22, 2024

Via Benzinga

TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades' ↗

June 03, 2024

Brenda Vingiello of Sand Hill Global Advisors named TJ Maxx's parent company, The TJX Companies Inc., as her final trade.

Via Benzinga

7 Overlooked Stocks That Belong in Every Portfolio ↗

June 03, 2024

Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.

Via InvestorPlace

3 No-Brainer Stocks to Buy in June ↗

June 02, 2024

Now is the time to invest in these great stocks.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 31, 2024

Via Benzinga

2 Generic Drug Makers With Growing Runways

May 31, 2024

Brand name drug costs continue to climb but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out.

Via MarketBeat

Topics Intellectual Property

A Must-Own Stock for Any Portfolio ↗

May 22, 2024

This company offers growth, high yield, and dividend growth.

Via The Motley Fool

2 Billion More Reasons to Buy AbbVie Stock ↗

May 22, 2024

This pharma giant just made a smart strategic acquisition.

Via The Motley Fool

3 Dividend Stocks to Double Up on Right Now ↗

May 30, 2024

The stories for these great dividend stocks are better than many might think.

Via The Motley Fool

7 Biotech Stocks to Put on Your Breakthrough Radar ↗

May 27, 2024

Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.

Via InvestorPlace

Forget Nvidia, Buy This Magnificent Healthcare Stock Instead ↗

May 26, 2024

AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.

Via The Motley Fool

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

May 25, 2024

These dividend stocks are ideal for investors seeking long-term passive income.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 24, 2024

Via Benzinga

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February ↗

May 24, 2024

Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.

Via Benzinga

Topics Data Breach

Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

May 24, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

3 Biotech Stocks to Buy on the Dip: May 2024 ↗

May 23, 2024

These biotech giants offer investors the best opportunity money can buy for excellent profits and returns this year.

Via InvestorPlace

Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

May 24, 2024

From FN Media Group LLC

Via GlobeNewswire

8 Health Care Stocks Whale Activity In Today's Session ↗

May 23, 2024

Via Benzinga

The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains ↗

May 22, 2024

Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.

Via InvestorPlace

7 Safe-Haven Stocks to Weather Any Storm ↗

May 22, 2024

Explore top safe-haven stocks to buy now for stability and consistent growth during economic turbulence and uncertainty.

Via InvestorPlace

3 S&P 500 Stocks That Have Proven Themselves Recession-Proof ↗

May 20, 2024

Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens.

Via InvestorPlace

Topics Stocks

1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165? ↗

May 20, 2024

Revenue growth during what should be a disastrous patent cliff is encouraging.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.